文献速递头颈部肿瘤放疗

头颈鳞癌影像学局部区域失败模式分析的系统综述与比例Meta分析

A systematic review and proportional meta-analysis of image-based pattern of loco-regional failure analyses outcomes in head and neck squamous cell carcinoma.
PubMed 文献 · Radiother Oncol · 2025-03-13

本系统综述与比例Meta分析纳入56项研究,汇总1,161例患者和658个失败位点的影像学局部区域失败模式分析数据,评估原发性放疗后头颈鳞癌失败发生于高剂量区域的比例。结果显示大多数失败为高剂量区域内失败, volumetric研究为84%(95%CI 77;90),起源点研究为82%(95%CI 61;85),覆盖CTV1处方剂量95%的失败为84%(95%CI 69;95)。作者认为应关注预测个体肿瘤放射敏感性的生物标志物以实现个体化治疗强化。

要点

  • 汇总1,161例患者和658个失败位点,大多数局部区域失败位于高剂量区域。
  • volumetric研究域内失败84%(95%CI 77;90),起源点研究域内失败82%(95%CI 61;85)。
  • 覆盖CTV1处方剂量95%的失败为84%(95%CI 69;95),近期治疗患者非高剂量失败比例呈增加趋势。

核心结论

  • 大多数原发性放疗后头颈鳞癌的局部区域失败与高剂量体积相关。
  • 作者认为有必要关注预测个体肿瘤放射敏感性的生物标志物,以实现个体化治疗强化来提高局部区域控制。

研究设计与样本

  • 系统综述与比例Meta分析,检索2000年至2023年数据库,纳入报告原发性放疗后头颈鳞癌影像学局部区域失败模式分析结果的研究,不限方法。
  • 共纳入56项研究,汇总1,161例患者和658个个体失败位点的影像学失败模式分析结果。
  • 在Prospero注册(CRD42023412545)。

主要发现

  • volumetric研究多数患者为域内失败,比例84%(95%CI 77;90)。
  • 起源点研究多数患者为域内失败,比例82%(95%CI 61;85)。
  • 覆盖CTV1处方剂量95%的失败比例为84%(95%CI 69;95)。
  • 观察到近期治疗患者中非高剂量失败比例呈增加趋势。

关键数值与推荐

  • volumetric研究域内失败(相对于边缘或野外失败)比例84%(95%CI 77;90)。
  • 起源点研究高剂量靶区内失败比例82%(95%CI 61;85)。
  • 覆盖CTV1处方剂量95%的失败比例84%(95%CI 69;95)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: The prognosis following loco-regional failure after primary radiotherapy (RT) for head and neck squamous cell carcinoma (HNSCC) is poor. The hypothesis that most failures occur as a consequence of tumor radioresistance, can be evaluated by proxy as the proportion of failures that occur in the high-dose region. Several studies have investigated possible reasons for treatment failure by an image-based pattern of failure analyses (POF), comparing the initial planning CT scan with a scan conducted upon failure. The aim of the present systematic review and meta-analysis was to evaluate the proportion of failures that occurred in the high-dose region of all analyzed failures. MATERIALS AND METHODS: A systematic database search from 2000 to 2023, was performed for studies including results from image-based loco-regional POF, regardless of the method, after primary RT for HNSCC. Proportions of volumetrically in-field (opposed to marginal or outfield) failures, point of origin-based inside high-dose targets, or covered by curative doses for both the number of patients and the number of failure sites were analyzed in proportional meta-analyses. The review was registered at Prospero (CRD42023412545). RESULTS: Out of 56 included studies, accumulated image-based POF results were available from 1,161 patients and 658 individual failure sites. The majority of patients had in-field failures in volumetric-based studies (84 % (95 % CI: 77;90)), inside failures in point of origin-based studies (82 % (95% CI:61;85)) or failures covered by 95 % of dose prescribed to CTV1 (84 % (95% CI:69;95)). A trend toward increasing proportions of non-high-dose failures in more recently treated patients was observed. CONCLUSION: Most loco-regional failures for patients treated with primary RT for HNSCC are related to the high-dose volume. Therefore, a focus on biomarkers predicting individual tumor radiosensitivity is warranted to enable individualized treatment intensification to increase loco-regional control.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Kristensen MH, Nielsen SB, Alsner J, et al. A systematic review and proportional meta-analysis of image-based pattern of loco-regional failure analyses outcomes in head and neck squamous cell carcinoma. Radiother Oncol. 2025. PMID: 40089161. doi:10.1016/j.radonc.2025.110838

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。